Comparison of pharmacokinetics of gatifloxacin in rats, dogs and humans
XD Liu,L Xie,J Wang,Y Liang,L Li,T Lu
2005-01-01
Abstract:Aim: To compare pharmacokinetic behaviors of gatifloxacin (AM-1155) in rats, dogs and humans. Methods: AM-1155 concentrations in plasma were determined by HPLC after oral administration and intravenous dose in rats, dogs and humans. The pharmacokinetic parameters were estimated using a standard non-compartmental method. Results: AM-1155 was rapidly absorbed in all species, and peak concentrations occurred at about 1, 1.73 and 1.3 h in rat, dog and human after oral administration. The pharmacokinetics of AM-1155 in rats was linear for both oral doses (7.5, 15 and 30 mg/kg) and intravenous doses (3.75, 7.5 and 15 mg·kg-1). The bioavailability in rat was 60.48%(15 mg·kg-1) to 78.86%(15 mg·kg-1). Higher bioavailability, with a mean of 98.47%, was found in dog. The elimination occurs fastest in rats and slowest in dog. After oral administration, the T1/2 estimated in rats, dogs and humans were 2.11, 12.53 and 7.32 h. The corresponding oral clearances(Cl/F) were 1.42, 0.095 and 0.188 l/kg/h, and oral apparent distribution volumes were 4.71, 1.71 and 1.96 l/kg. Exposure AUC normalized by body surface area and dose in dogs was 4.5-fold of that in human. Conclusion: There exists species difference in the pharmacokinetics of AM-1155. Dogs have higher exposure than humans and rat do.